Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Giobbie-Hurder, Anita; Price, Karen; Gelber, Richard

doi:10.1177/1740774509105380

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Atıf İçin Kopyala

Giobbie-Hurder A., Price K. N., Gelber R. D.

CLINICAL TRIALS, cilt.6, sa.3, ss.272-287, 2009 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 6 Sayı: 3
Basım Tarihi: 2009
Doi Numarası: 10.1177/1740774509105380
Dergi Adı: CLINICAL TRIALS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.272-287
İstanbul Üniversitesi Adresli: Hayır

Özet

Background Aromatase inhibitors provide superior disease control when compared with tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer.